AOCI at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s AOCI?
- Edgewise Therapeutics, Inc. (EWTX) reported AOCI of -$252K in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s AOCI changed year-over-year?
- Edgewise Therapeutics, Inc.'s AOCI decreased by 162.8% year-over-year, from $401K to -$252K.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s AOCI?
- Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s AOCI has grown at a 7.1% compound annual growth rate (CAGR), from -$514K to $677K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.